Litcius/Paper detail

Tofacitinib for refractory chilblain lupus erythematosus

Scott A. Elman, Daniel R. Mazori, Joseph F. Merola

2021International Journal of Dermatology12 citationsDOI

Topics & Concepts

MedicineDermatologyFamily medicineDermatological and COVID-19 studiesParvovirus B19 Infection StudiesInflammasome and immune disorders
Tofacitinib for refractory chilblain lupus erythematosus | Litcius